Clinical Trial Update: Study on the Treatment of Prurigo Nodularis With Stapokibart Injection [Phase 3]

View source ↗

Summary

A Phase 3 trial of Stapokibart Injection for Prurigo nodularis is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Stapokibart Injection (Stapokibart)

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Prurigo Nodularis | Phase 3 | Status: ACTIVE_NOT_RECRUITING